Insider Shareholders with Direct Ownership of Clearside Biomedical, Inc. (CLSD)
This section provides a comprehensive overview of the insiders with direct ownership of Clearside Biomedical, Inc. (CLSD). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Clearside Biomedical, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bradford T Whitmore
> 10% Shareholder |
1,160,067 | 0 | 4,495,034 $4.58 Million | 9 |
Feb 07, 2024
Added 9.0%
|
| 237,750 | 73,862 | 466,577 $475,908 | 11 |
Jan 19, 2024
Reduced 3.71%
|
|
|
Charles A. Deignan
Chief Financial Officer |
197,836 | 41,501 | 384,662 $392,355 | 9 |
Jan 19, 2024
Reduced 3.24%
|
|
Thomas Ciulla
Chief Medical Officer |
156,875 | 27,480 | 291,890 $297,727 | 8 |
Jan 20, 2023
Reduced 4.48%
|
| 100,000 | 0 | 100,000 $102,000 | 2 |
Apr 18, 2024
Added 48.26%
|
|
| 88,000 | 0 | 93,000 $94,860 | 5 |
Oct 03, 2023
Added 9.71%
|
|
|
Ngai Hang Victor Chong
Chief Medical Officer |
53,500 | 0 | 63,500 $64,770 | 2 |
Jun 24, 2024
Added 27.01%
|
| 45,454 | 0 | 51,040 $52,060 | 2 |
Sep 22, 2023
Added 30.81%
|
|
| 32,522 | 0 | 40,522 $41,332 | 3 |
Sep 25, 2023
Added 19.79%
|
|
| 7,813 | 0 | 17,957 $18,316 | 1 |
May 15, 2024
Added 30.32%
|